Puma, Michael Kors, ASUS and Garmin unveil new smartwatches
The first two are running Google's Wear OS, ASUS' device packs an ECG & PPG sensors, and Garmin has likely launched a new smartwatch series...
iRhythm, Verily to develop health management solutions for Atrial Fibrillation patients
The two companies aim to collaborate on solutions providing early warnings, enabling the identification of patients that could otherwise go undiagnosed.
Datica unveils new health data integration platform
Called Datica Integrate, it combines healthcare data integration and compliance, enabling the development of HIPAA-compliant healthcare apps in the cloud.
ONCOassist launches clinical trial search engine
The solution enables often busy and under pressure oncology clinicians to access relevant, up to date tools and content at their fingertips.
Pinterest now displaying information from health organizations for vaccine-related searches
The latest move comes as part of the social media's efforts against health misinformation, which earlier included blocking of vaccination-related search terms.
AmblyoPlay brings its vision therapy solution for “lazy eye” to the U.S.
Game-based home therapy utilizes personalized training technology to actively treat amblyopia in both children and adults.
Fitbit’s Premium service to deliver personalized guidance
Premium will start rolling out in September 2019 at $9.99 per month or $79.99 per year. It will be available in English in 17 countries via the Fitbit app.
Fitbit Versa 2 announced, it’s the best smartwatch for Android users
The device comes with an OLED screen, faster processor, improved battery life and Alexa support.
Singapore, Fitbit team-up over a nationwide public health program
This is Fitbit's first major integration of a digital health platform and wearables into a national public health program globally.
Research: $54bn wearable tech industry offers immense opportunity for healthcare by 2023
However, there are many barriers that must be overcome before widespread adoption including cost, reimbursement, data quality and lack of clinical evidence.









